Volume 29, Number 7—July 2023
CME ACTIVITY - Research
Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus
Table 2
Comparison of mucormycosis caused by Rhizopus homothallicus versus R. arrhizus in patients enrolled in a 10-month retrospective study, Chandigarh, India, January–October 2021*
Parameter | R. homothallicus, n = 41 | R. arrhizus, n = 266 | p value |
---|---|---|---|
Mean age, y (+ SD) |
45.9 (± 12.8) |
52.5 (± 12.7) |
0.002 |
Sex | |||
M | 23/41 (56.1) | 182/266 (68.4) | 0.15 |
F |
18/41 (43.9) |
84/266 (31.6) |
|
Risk factors | |||
CAM | 23/41 (56.1) | 256/266 (96.2) | 0.0001 |
Duration after COVID-19, d (+ SD) | 6.13 (± 13.5) | 11.9 (± 14.8) | 0.07 |
Diabetes mellitus | 39/41 (95.1) | 223/238 (93.7) | 0.72 |
Recently diagnosed diabetes mellitus | 9/39 (23.1) | 54/223 (24.2) | |
Renal transplantation |
0 |
1/238 (0.4) |
1.00 |
Intracranial involvement |
3/41 (7.3) |
13/266 (4.9) |
0.46 |
Clinical features | |||
Fever | 4/41 (9.8) | 3/55 (5.5) | 0.42 |
Headache | 4/41 (9.8) | 10/55 (18.2) | 0.38 |
Toothache | 4/41 (9.8) | 5/55 (9.1) | 0.91 |
Eye swelling | 27/41 (65.9) | 27/55 (49.1) | 0.10 |
Facial pain | 11/41 (26.8) | 22/55 (40) | 0.18 |
Facial swelling | 16/41 (39) | 22/55 (40) | 0.92 |
Proptosis | 3/41 (7.3) | 0 | 0.08 |
Visual disturbance | 18/41 (43.9) | 7/55 (12.7) | 0.0005 |
Oral ulcer | 3/41 (7.3) | 10/55 (18.2) | 0.12 |
Nasal crust | 5/41 (12.2) | 5/55 (9.1) | 0.62 |
Palatal eschar |
5/41 (12.2) |
10/55 (18.2) |
0.42 |
Management | |||
Amphotericin therapy | 38/41 (92.7) | 212/218 (97.2) | 0.14 |
LAMB | 36/38 (94.7) | 196/212 (92.5) | |
Conventional AMB | 2/38 (5.3) | 16/212 (7.5) | |
Surgery |
24/36 (66.7) |
184/245 (75.1) |
0.31 |
30-day mortality | 4/41 (9.8) | 104/266 (39.1) | 0.0001 |
*Values are no. patients/no. with data available (%) except as indicated. CAM, COVID-19–associated mucormycosis; LAMB, liposomal amphotericin B; AMB, amphotericin.
1These first authors contributed equally to this article.
2Current affiliation: Dr. B R Ambedkar State Institute of Medical Sciences, Mohali, India.
3Current affiliation: Indian Council of Medical Research, New Delhi, India.
4Current affiliation: Doodhadhari Burfani Hospital, Haridwar, India.